Bristol-Myers Squibb Co. (BMY) Tops Q1 EPS by 3c; Boosts FY14 Profit Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $59.12 -0.77%
Revenue Growth %: +3.4%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
HOVR, VFS, PGR, More
Revenue Growth %: +3.4%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.46, $0.03 better than the analyst estimate of $0.43. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.89 billion.
Bristol-Myers Squibb Co. sees FY2014 EPS of $1.70-$1.80, versus prior guidance of $1.65-$1.80 and the consensus of $1.78. Sees worldwide revenues between $15.2 billion and $15.8 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- StoneX Reiterates Buy Rating on Marcus Corp. (MCS)
- Alibaba ADR climbs on analyst upgrades, AI momentum
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
